Biotech

Festival of Biologics USA 2027

The Festival of Biologics USA is America’s most comprehensive biologics event, covering the entire industry from antibody therapies, cell and gene therapies, immunotherapies, to biosimilars. It brings together 2,000+ attendees from pharma, biotech, start-ups, academia, regulators and investors for two days of presentations, panels, networking, and workshops.…

Visit the official siteRegisterSponsorship open
53Speakers
61Sponsors
1Exhibitors
8On the bill · sessions
66Companies · in total
§I

Speakers

Programmed at Festival, in alphabetical order.
Adrian Hugenmatter
Stanford University
Andrew Tsourkas
Professor of Bioengineering · University of Pennsylvania
Anne Kerber
Senior Vice President, Head Cell Therapy Development · Bristol Myers Squibb
Brian Avanzino
Director of Discovery Research · Rondo Therapeutics
Changchun Du
Senior Principal Scientific Researcher · Genentech
Cheryl Marcotte
Sr Director · GSK
Chris Mason
Professor of Cell and Gene Therapy · UCL
Daniela Cipolletta
Senior Director of Immunology · Seismic Therapeutic
Dirk Zajonc
Exec Dir, Protein Engineering · Mirador Therapeutics
Emanuela Lacana
Deputy Director, Office of Therapeutic Biologics and Biosimilars/ OND/ CDER · FDA
Eugene Zhukovsy
Vice President and Site Head of Biologics R&D · Orion Pharma
Gaurav Hirani
General Manager — Cloud and AIOps · Jio
Gillian Woollett
Head of Regulatory Strategy & Policy · Samsung Bioepis
Greg Hammond
Associate Director · BioTalent
Hans Van Der Vliet
Medical Oncologist · Amsterdam UMC
Huub Gelderblom
Director · Fred Hutch
Isabell Remus
Global Head of Biosimilars · Sandoz
Jae Sly
CEO · Pathways Preclinical Partners
Jakub Tomala
Assistant Research Professor · John Hopkins University
Jane Seagal
VP of Antibody Discovery · AlivaMab Discovery Services
Jay Mandrekar
Professor of Biostatistics & Neurology · Mayo Clinic
John Lambert
Independent Consultant, Former EVP and CSO · Immunogen
§II

Sponsors

The houses behind the program. Tiers as disclosed.
3T Biosciences
AbbVie
AIVITA Biomedical, Inc.
AlivaMab Discovery Services
Amgen
Amsterdam UMC
Arscientia
Biodesign Institute at Arizona State University
Biogen
Biolojic Design
BioTalent
Bristol Myers Squibb
Buzz Biolabs
Diachi Sankyo
Eli Lilly
Exreprotein LLC
Fate Therapeutics
FDA
Fred Hutch
Fujifilm
Genentech
Genevation LTD
Gilead
Gritstone Bio
GSK
Icosagen
Immunogen
ImYoo Health
Ipca Laboratories Ltd
isla
John Hopkins University
Kennesaw State University
Lasanth Consulting
Mayo Clinic
Memorial Sloan-Kettering Cancer Center
Mirador Therapeutics
MJH Life Sciences
MSKCC
Mucommune
Northeastern University
§III

Agenda

Selected from 8 sessions on the bill.
  • Nov 18 11:40

    Ai-driven strategies for the next-gen cloud: Building the telecom playbook

    NETWORK
  • Nov 18 11:40

    AI in action — Personalising services and transforming customer experience

    CUSTOMER
  • Nov 18 11:40

    Infrastructure sharing models: Collaborating and competing

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: From predicting problems to optimising outcomes and delivering dollars — is AI the answer?

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: NaaS for telco operators in Asia: Cloud first, cloud only?

    NETWORK
  • Nov 18 12:00

    The Telco AI Trifecta – Enabling autonomous, customer-centric networks

    CUSTOMER
  • Nov 18 9:15

    Organiser’s Welcome

    Keynotes
  • Nov 18 9:30

    KEYNOTE PANEL: AI — faster, leaner, smarter... is the telco of tomorrow already today?

    Keynotes
Intermission
Part the Second · For the Buyer

What does it mean when 66 companies show up — and 44 bet on three roles at once?

66 companies. 44 are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
44All threespeak · spons · exh
17Sponsoringsponsor only
1Exhibitingexhibitor only
4Companies Speakingspeaker only

The Triple-Threat

FDA·Rondo Therapeutics·Sanofi·University of California San Diego·3T Biosciences·AbbVie·AIVITA Biomedical, Inc.·AlivaMab Discovery Services·Amsterdam UMC·Biodesign Institute at Arizona State University·Biolojic Design·BioTalent·Bristol Myers Squibb·Buzz Biolabs·Eli Lilly·Fate Therapeutics·Fred Hutch·Genentech·Genevation LTD·GSK·Immunogen·ImYoo Health

Speakers by seniority

58% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite815%
  • Founder / Owner12%
  • VP-level815%
  • Director / Head of1426%
  • Manager / Lead12%
  • Research / Science48%
  • Advisor / Investor24%
  • Other roles1528%

Of 53 on the bill · classified by free-text title

Most-represented companies
  1. 01FDASp2V
  2. 02Rondo TherapeuticsSp2V
  3. 03SanofiSp2V
  4. 04University of California San DiegoSp2V
  5. 053T BiosciencesSp1V
  6. 06AbbVieSp1V
  7. 07AIVITA Biomedical, Inc.Sp1V
  8. 08AlivaMab Discovery ServicesSp1V
  9. 09Amsterdam UMCSp1V
  10. 10Biodesign Institute at Arizona State UniversitySp1V
  11. 11Biolojic DesignSp1V
  12. 12BioTalentSp1V
  13. 13Bristol Myers SquibbSp1V
  14. 14Buzz BiolabsSp1V
Sponsors by tier
unspecified61
100% of 61
At peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

Related events · by shared sponsors